During the open enrollment period, it is extremely important that Medicare beneficiaries review their prescription coverage ...

The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may ...

The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some ...

The agency’s decision to conceal drug names on inspection reports has prevented doctors, pharmacists and patients from ...

Developers of biosimilars -- medicines that are near-identical copies of biologic drugs -- will no longer be required to conduct clinical trials to prove effectiveness.

Under the agreement, Eli Lilly will continue to market tirzepatide under brand name Mounjaro, while Cipla will have the ...

President Donald Trump’s top health advisers announced a push to cut health costs by bringing more cutting-edge generic drugs ...

For those paying the full cost of medications, the new model will reduce the monthly cost for brand-name prescriptions by an ...

Our gut is full of tiny creatures that help us digest our food, protect us from harmful intruders, and act as the telephone ...

Cipla will market Eli Lilly's weight loss drug Yurpeak in India, manufactured by Lilly, offering personalized treatment ...

During his first term in office, President Trump’s FDA approved abortion pill manufacturer GenBioPro’s abbreviated new drug ...